BioClinica, Inc. (BIOC) Releases OnPoint Platform, Notes Increased Industry Demand

QualityStocks would like to highlight BioClinica, Inc. (NASDAQ: BIOC), a leading global provider of integrated, technology-enhanced clinical trial management solutions. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, clinical trial management, and clinical supply chain design and optimization solutions.

In the company’s news yesterday,

BioClinica announced the release of its BioClinica OnPoint platform, which it acquired from TranSenda in 2010.

The company highlighted industry trends migrating toward collaborative technology that can be integrated with existing systems.

“A quiet transformation of clinical study architectures is occurring in the industry through the increased use of standard collaboration tools for clinical study management and regulatory document management,” Gartner Research Vice President Steve Lefebure stated in the press release. “Life science companies are seeking to leverage existing infrastructure, support collaboration, and create flexibility. Solutions that leverage both industry standard collaboration tools and office automation software while providing comprehensive clinical study management capabilities present significant advantages in this environment.”

OnPoint allows sponsors of clinical trials and CROs to access, share and analyze operational trial data using Microsoft® SharePoint standard collaboration and office automation tools. OnPoint’s integration with SharePoint enables users to interact with the system using Microsoft Office applications such as Outlook, Excel and Word. This feature offers organizations lower cost of ownership.

BioClinica also noted increasing demands for CTMS technology and the company’s project pipeline for the current quarter.

“We are experiencing extremely strong interest for OnPoint CTMS,” said Peter Benton, president of eClinical Solutions for BioClinica. “So far in this quarter we have already received contract awards from four pharma and device companies that range from mid to large in size. The combination of features, value and fast implementation – augmented by OnPoint’s out-of-the-box integration with SharePoint – is changing market perceptions of CTMS’ utility and cost-effectiveness.”

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.